Impact of combined endoscopic therapy on progression-free survival in patients with primary tracheal cancers: a multivariate-adjusted retrospective cohort study
Jiayao Wang, Yahan Xu, Tao Wang · 2025
Read Impact of combined endoscopic therapy on progression-free survival in patients with primary tracheal cancers: a multivariate-adjusted retrospective cohort study by Jiayao Wang, Yahan Xu, Tao Wang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12829292.txt.
Description
Cancer of the windpipe is rare, and surgery alone often fails to hold it back. Jiayao Wang, Yahan Xu, and Tao Wang review 39 patients treated at one center between 2015 and 2020. One group had surgery only; the other had surgery plus endoscopic treatment delivered through the airway.
The combined group went a median of about 55 months without the disease progressing, against about 36 months for surgery alone, a clear gap. Five-year survival also leaned toward the combined group, about 67 versus 57 percent, though less firmly. In the main cancer subtype the same trend appeared without reaching firm significance. Side effects stayed mild to moderate, with no severe events. The authors call the pairing a safe, effective strategy for this uncommon cancer.
Catalog record
| CREATOR | Jiayao Wang, Yahan Xu, Tao Wang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |